Cationic Dendrimer G2-S16 Inhibits Herpes Simplex Type 2 Infection and Protects Mice Vaginal Microbiome.

Carlos Guerrero-Beltrán, Inmaculada Garcia-Heredia, Rafael Ceña-Diez, Ignacio Rodriguez-Izquierdo, María Jesús Serramía, Francisco Martinez-Hernandez, Mónica Lluesma-Gomez, Manuel Martinez-Garcia, María Ángeles Muñoz-Fernández
Author Information
  1. Carlos Guerrero-Beltrán: Immunology Section, Head Inmuno-Biology Molecular Laboratoy, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Spanish HIV HGM BioBank, C/Dr. Esquerdo 46, 28007 Madrid, Spain.
  2. Inmaculada Garcia-Heredia: Department of Physiology, Genetics, and Microbiology, University of Alicante, C/San Vicente s/n, 03080 Alicante, Spain.
  3. Rafael Ceña-Diez: Immunology Section, Head Inmuno-Biology Molecular Laboratoy, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Spanish HIV HGM BioBank, C/Dr. Esquerdo 46, 28007 Madrid, Spain.
  4. Ignacio Rodriguez-Izquierdo: Immunology Section, Head Inmuno-Biology Molecular Laboratoy, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Spanish HIV HGM BioBank, C/Dr. Esquerdo 46, 28007 Madrid, Spain.
  5. María Jesús Serramía: Immunology Section, Head Inmuno-Biology Molecular Laboratoy, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Spanish HIV HGM BioBank, C/Dr. Esquerdo 46, 28007 Madrid, Spain.
  6. Francisco Martinez-Hernandez: Department of Physiology, Genetics, and Microbiology, University of Alicante, C/San Vicente s/n, 03080 Alicante, Spain.
  7. Mónica Lluesma-Gomez: Department of Physiology, Genetics, and Microbiology, University of Alicante, C/San Vicente s/n, 03080 Alicante, Spain.
  8. Manuel Martinez-Garcia: Department of Physiology, Genetics, and Microbiology, University of Alicante, C/San Vicente s/n, 03080 Alicante, Spain. ORCID
  9. María Ángeles Muñoz-Fernández: Immunology Section, Head Inmuno-Biology Molecular Laboratoy, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Spanish HIV HGM BioBank, C/Dr. Esquerdo 46, 28007 Madrid, Spain.

Abstract

The G2-S16 polyanionic carbosilane dendrimer is a promising microbicide that inhibits HSV-2 infection in vitro and in vivo in mice models. This G2-S16 dendrimer inhibits HSV-2 infection even in the presence of semen. Murine models, such as BALB/c female mice, are generally used to characterize host-pathogen interactions within the vaginal tract. However, the composition of endogenous vaginal flora remains largely undefined with modern microbiome analyses. It is important to note that the G2-S16 dendrimer does not change healthy mouse vaginal microbiome where (10.2-79.1%) and (0.7-13%) are the more abundant genera. The HSV-2 vaginally infected female mice showed a significant microbiome alteration because an increase of (up to 98.8%) and (30.76%) levels were observed becoming these bacteria the predominant genera. BALB/c female mice vaginally-treated with the G2-S16 dendrimer and infected with the HSV-2 maintained a healthy vaginal microbiome similar to uninfected female mice. Summarizing, the G2-S16 polyanionic carbosilane dendrimer inhibits the HSV-2 infection in the presence of semen and prevents the alteration of mice female vaginal microbiome.

Keywords

References

  1. Nanomedicine. 2015 Aug;11(6):1299-308 [PMID: 25959924]
  2. Curr HIV/AIDS Rep. 2017 Oct;14(5):153-160 [PMID: 28812207]
  3. Dalton Trans. 2012 Nov 7;41(41):12733-48 [PMID: 22968584]
  4. Front Vet Sci. 2014 Oct 15;1:19 [PMID: 26664918]
  5. Clin Infect Dis. 2005 May 15;40(10):1422-8 [PMID: 15844064]
  6. J Immunol. 2001 Mar 1;166(5):3451-7 [PMID: 11207303]
  7. J Virol. 2013 Dec;87(23):12583-91 [PMID: 24027327]
  8. PLoS One. 2016 Jan 19;11(1):e0145760 [PMID: 26785250]
  9. BMC Microbiol. 2013 Dec 28;13:303 [PMID: 24373613]
  10. J Exp Zool. 1977 Oct;202(1):121-8 [PMID: 21936]
  11. J Clin Invest. 2011 Dec;121(12):4610-7 [PMID: 22133886]
  12. AIDS. 2013 May 15;27(8):1219-29 [PMID: 23925376]
  13. mBio. 2012 Dec 18;3(6): [PMID: 23249810]
  14. Med Res Rev. 2017 Jan;37(1):149-179 [PMID: 27518199]
  15. Ecol Lett. 2006 Jun;9(6):683-93 [PMID: 16706913]
  16. Bioinformatics. 2014 Aug 1;30(15):2114-20 [PMID: 24695404]
  17. J Virol. 2003 Dec;77(23):12742-52 [PMID: 14610196]
  18. J Infect Dis. 2015 Jul 1;212(1):8-17 [PMID: 25589333]
  19. Lab Invest. 1994 Mar;70(3):369-80 [PMID: 8145530]
  20. J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):238-44 [PMID: 21860356]
  21. Nanoscale. 2017 Jul 13;9(27):9732-9742 [PMID: 28675217]
  22. J Clin Med Res. 2013 Aug;5(4):309-15 [PMID: 23864922]
  23. Clin Microbiol Rev. 2010 Apr;23(2):253-73 [PMID: 20375352]
  24. AIDS. 2008 Jul 31;22(12):1493-501 [PMID: 18614873]
  25. Ann Ig. 2013 Sep-Oct;25(5):443-56 [PMID: 24048183]
  26. Curr Infect Dis Rep. 2001 Apr;3(2):152-155 [PMID: 11286657]
  27. Front Microbiol. 2016 Dec 08;7:1936 [PMID: 28008325]
  28. Science. 2017 Jun 2;356(6341):938-945 [PMID: 28572388]
  29. Lancet. 1997 Oct 25;350(9086):1251-2 [PMID: 9652590]
  30. J Control Release. 2012 Aug 10;161(3):949-58 [PMID: 22652549]
  31. Eur J Pharmacol. 2017 Sep 15;811:155-163 [PMID: 28577966]
  32. AIDS. 2018 Mar 27;32(6):687-698 [PMID: 29424773]
  33. Viruses. 2015 Apr 20;7(4):2057-73 [PMID: 25903833]
  34. PLoS Med. 2017 Dec 27;14(12):e1002478 [PMID: 29281632]
  35. Retrovirology. 2009 Mar 09;6:27 [PMID: 19272145]
  36. Obstet Gynecol. 2017 Apr;129(4):643-654 [PMID: 28277350]
  37. Science. 2008 Jul 25;321(5888):532-4 [PMID: 18653884]
  38. Bioinformatics. 2016 Sep 15;32(18):2760-7 [PMID: 27259541]
  39. PLoS One. 2007 Jan 10;2(1):e147 [PMID: 17215958]
  40. FEMS Microbiol Rev. 2013 Sep;37(5):762-92 [PMID: 23789590]
  41. Science. 2010 Sep 3;329(5996):1168-74 [PMID: 20643915]
  42. J Virol. 2009 Jan;83(1):73-80 [PMID: 18945786]
  43. Int J Nanomedicine. 2016 May 19;11:2147-62 [PMID: 27274240]
  44. PLoS One. 2010 Apr 15;5(4):e10197 [PMID: 20419168]
  45. Sci Rep. 2017 Nov 13;7(1):15475 [PMID: 29133803]
  46. Nat Rev Microbiol. 2018 Jul;16(7):410-422 [PMID: 29795328]
  47. Pathog Dis. 2015 Jun;73(4): [PMID: 25761873]
  48. Sci Transl Med. 2014 Nov 12;6(262):262ra157 [PMID: 25391483]

Grants

  1. RD16/0025/0019; PT17/0015/0042; PI16/01863; PI19/01638; CIBER-BBN/Instituto de Salud Carlos III
  2. EPIICAL Project/PENTA FOUNDATION
  3. NAWA International Academic Partnership Programme/Uniwersytet Łódzki
  4. COST Action CA 17140 "Cancer Nanomedicine from the Bench to the Bedside"/European Cooperation in Science and Technology
  5. CGL2013-40564-R/Ministerio de Economía y Competitividad
  6. 5334/Gordon and Betty Moore Foundation

Word Cloud

Created with Highcharts 10.0.0G2-S16micedendrimerHSV-2femalevaginalmicrobiomepolyanioniccarbosilaneinhibitsinfectionsemenmicrobicidemodelspresenceBALB/chealthygenerainfectedalterationpromisingvitrovivoevenMurinegenerallyusedcharacterizehost-pathogeninteractionswithintractHowevercompositionendogenousfloraremainslargelyundefinedmodernanalysesimportantnotechangemouse102-791%07-13%abundantvaginallyshowedsignificantincrease988%3076%levelsobservedbecomingbacteriapredominantvaginally-treatedmaintainedsimilaruninfectedSummarizingpreventsCationicDendrimerInhibitsHerpesSimplexType2InfectionProtectsMiceVaginalMicrobiomeHCV

Similar Articles

Cited By (9)